Pharmafile Logo
Pharmafocus logo
Advanced Search
Kent Woods

MHRA plans to cut red tape in the UK

March 13, 2012
Manufacturing and Production EU, MHRA, pharma

The UK government’s drug safety regulator is calling on the pharma industry to help it eliminate unneccessary bureaucracy.The Medicines and …

News
john_brown

Dr John Brown joins BioCity Nottingham’s board

March 13, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown

Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …

Appointment

GSK expands apprenticeship programme

March 13, 2012
Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D.  The multi-disciplinary scheme is …

News
Xarelto picture

NICE wants more information on Xarelto

March 13, 2012
Sales and Marketing Bayer, DVT, NICE, Xarelto

NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance.  The watchdog is currently minded …

News
Sanofi glucose monitor

Sanofi’s new diabetes device: worth the price?

March 12, 2012
Medical Communications NHS, Sanofi, app, diabetes, iBGStar, smartphone

Sanofi launched its new iPhone and iPod Touch blood sugar monitor to much fanfare this week, but its high price …

News

WHO joins regulators in manufacturing inspections alliance

March 12, 2012
Manufacturing and Production API, EMA, FDA, WHO, manufacturing

The World Health Organization will join a shared inspection programme for active pharmaceutical ingredient (API) facilities piloted last year by …

News
Zytiga image

Strong Zytiga study results could increase uptake

March 12, 2012
Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate

Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …

News
Sanofi glucose monitor

Sanofi launches iPhone and iPod glucose monitor in the UK

March 12, 2012
Medical Communications, Sales and Marketing BGStar, Sanofi, diabetes, iPod, iphone

Sanofi has launched a new diabetes device in the UK to help patients monitor their blood sugar levels from their …

News

Patheon swings to loss on terminated manufacturing contract

March 12, 2012
Manufacturing and Production Patheon, fiscal, manufacturing, operating

Contract manufacturing and development organisation Patheon said it posted an operating loss in its fiscal first quarter results after losing …

News
roch_d_ucb

UCB chief executive to chair IMI

March 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB

UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …

Appointment
FDA picture

Prescription drugs could become OTC under FDA plans

March 12, 2012
Sales and Marketing COPD, FDA, OTC, prescribing

The FDA is considering new plans to make drugs for chronic conditions available over-the-counter. These drugs could include medicines for …

News

India’s Nexavar patent ruling disturbs pharma

March 12, 2012
Sales and Marketing India, emerging markets, intellectual property, patents

India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …

News

Government could be forced to publish risk register

March 9, 2012
Sales and Marketing Healey, NHS, reforms, risk

The government has lost its appeal to keep details about the risks involved in the reform of the NHS secret.  …

News
caprelsa image

Major new drugs for 2012

March 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta

 Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …

Feature
Vader image

Battle against prostate cancer gains celebrity endorsement

March 9, 2012
Medical Communications M&S, MS, Vader, prostate

A famous DJ and a legendary Star Wars actor have joined forces to raise awareness of prostate cancer. Star Wars …

News
mark_archer_013

inVentiv appoints former Quintiles man Mark Archer

March 9, 2012
Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv

Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …

Appointment

Government touts telehealth scheme

March 9, 2012
Medical Communications, Sales and Marketing NHS, king's fund, telecare, telehealth

The government has said that telehealth and telecare technology could save the NHS £1.2 billion over the next five years.  …

News
screen_shot_2012-03-09_at_09

New website launched to help people with psoriasis

March 9, 2012
Medical Communications 360. PM soc, Twitter, psoriasis

A new online resource for patients with psoriasis has been set up to help them understand and manage their disease. …

News
Victrelis picture

NICE recommends Victrelis in speedy review

March 9, 2012
Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis

NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review.  In its final …

News
rachel_terry

Aurora bolsters senior team with new director

March 8, 2012
Business Services, Medical Communications, Sales and Marketing Aurora, LoweFusion, Pan

Aurora has appointed Rachel Terry as its new director.Terry was previously director of healthcare at Burson-Marsteller until the end of …

Appointment
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026